{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T10:25:25Z","timestamp":1789295125963,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.dld.2026.01.224","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:32:16Z","timestamp":1771849936000},"page":"630-637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring novel biomarkers in pediatric ulcerative colitis: The role of Lipocalin-2, MMP-9, and MMP-9\/LCN-2 complex"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9000-2584","authenticated-orcid":false,"given":"Giulia","family":"D'Arcangelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7020-1471","authenticated-orcid":false,"given":"Roberto","family":"Paparella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gravina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7412-2279","authenticated-orcid":false,"given":"Marina","family":"Aloi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0651-1816","authenticated-orcid":false,"given":"Carla","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2026.01.224_bib0001","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/ecco-jcc\/jjab050","article-title":"Results of the seventh scientific workshop of ecco: precision medicine in ibd-disease outcome and response to therapy","volume":"15","author":"Verstockt","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2026.01.224_bib0002","first-page":"1","article-title":"Inflammatory bowel disease in children and adolescents: recommendations for diagnosis\u2013the Porto criteria","volume":"41","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2026.01.224_bib0003","first-page":"S53","article-title":"Pediatric endoscopy quality improvement network pediatric endoscopy reporting elements: a joint naspghan\/espghan guideline","volume":"74","author":"Walsh","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2026.01.224_bib0004","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/ibd\/izz078","article-title":"Challenges in ibd research: precision medicine","volume":"25","author":"Denson","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2026.01.224_bib0005","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2026.01.224_bib0006","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/MIB.0000000000001082","article-title":"Clinical utility of fecal calprotectin monitoring in asymptomatic patients with inflammatory bowel disease: a systematic review and practical guide","volume":"23","author":"Heida","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2026.01.224_bib0007","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","article-title":"Lipocalin-2: a master mediator of intestinal and metabolic inflammation","volume":"28","author":"Moschen","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.dld.2026.01.224_bib0008","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00535-011-0516-5","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity","volume":"47","author":"Oikonomou","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2026.01.224_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044328","article-title":"Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation","volume":"7","author":"Chassaing","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2026.01.224_bib0010","first-page":"2327","article-title":"Lipocalin-2 is a disease activity marker in inflammatory bowel disease regulated by IL-17A, IL-22, and TNF-\u03b1 and modulated by IL23R genotype status","volume":"21","author":"Stallhofer","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2026.01.224_bib0011","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.lfs.2010.10.026","article-title":"Role of anti-angiogenic factor endostatin in the pathogenesis of experimental ulcerative colitis","volume":"88","author":"Tolstanova","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.dld.2026.01.224_bib0012","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40001-024-01695-w","article-title":"Effect of huankuile on colon injury in rats with ulcerative colitis by reducing TNF-\u03b1 and MMP9","volume":"29","author":"Wushouer","year":"2024","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.dld.2026.01.224_bib0013","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/MIB.0000000000000068","article-title":"Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis","volume":"20","author":"de Bruyn","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2026.01.224_bib0014","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ibd.20419","article-title":"Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease","volume":"14","author":"Manfredi","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2026.01.224_bib0015","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/jgh.12597","article-title":"Neutrophil gelatinase-associated lipocalin in blood in children with inflammatory bowel disease","volume":"29","author":"Janas","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.01.224_bib0016","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/jpn3.70015","article-title":"Evaluation of fecal neutrophil gelatinase-associated lipocalin levels in childhood inflammatory bowel disease","volume":"80","author":"Kardas Yildiz","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2026.01.224_bib0017","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2026.01.224_bib0018","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ibd.21493","article-title":"Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification","volume":"17","author":"Levine","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2026.01.224_bib0019","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study","volume":"133","author":"Turner","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2026.01.224_bib0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","article-title":"Developing an instrument to assess the endoscopic severity of ulcerative colitis: the ulcerative colitis endoscopic index of severity (UCEIS)","volume":"61","author":"Travis","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2026.01.224_bib0021","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.23606","article-title":"C-reactive protein and colorectal cancer risk: a systematic review of prospective studies","volume":"123","author":"Tsilidis","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2026.01.224_bib0022","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.cgh.2008.06.010","article-title":"Relationships between disease activity and serum and fecal biomarkers in patients with Crohn\u2019s disease","volume":"6","author":"Jones","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.01.224_bib0023","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","author":"Lin","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2026.01.224_bib0024","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5114\/aoms.2014.43672","article-title":"Is faecal calprotectin equally useful in all Crohn\u2019s disease locations? A prospective, comparative study","volume":"11","author":"Stawczyk-Eder","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.dld.2026.01.224_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ecco-jcc\/jjaa124","article-title":"Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study","volume":"15","author":"Zollner","year":"2021","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2026.01.224_bib0026","first-page":"26","article-title":"The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis","volume":"9","author":"Lasson","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2026.01.224_bib0027","first-page":"2683","article-title":"Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm","volume":"96","author":"Husebye","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2026.01.224_bib0028","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/2050640616686517","article-title":"Compliance with the faecal calprotectin test in patients with inflammatory bowel disease. United","volume":"5","author":"Mar\u00e9chal","year":"2017","journal-title":"European Gastroenterol J"},{"key":"10.1016\/j.dld.2026.01.224_bib0029","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/ph16020324","article-title":"Mucosal genes expression in inflammatory bowel disease patients: new insights","volume":"16","author":"Alarfaj","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.dld.2026.01.224_bib0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41385-018-0086-4","article-title":"NOX1-derived ROS drive the expression of Lipocalin-2 in colonic epithelial cells in inflammatory conditions","volume":"12","author":"Makhezer","year":"2019","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.dld.2026.01.224_bib0031","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/dmrr.2493","article-title":"Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis","volume":"30","author":"Wu","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.dld.2026.01.224_bib0032","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3109\/1354750X.2015.1123354","article-title":"The potential of lipocalin-2\/NGAL as biomarker for inflammatory and metabolic diseases","volume":"20","author":"Abella","year":"2015","journal-title":"Biomarkers"},{"key":"10.1016\/j.dld.2026.01.224_bib0033","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.3390\/ijms21176044","article-title":"Colonic Mucosal Microbiota and Association of Bacterial Taxa with the Expression of Host Antimicrobial Peptides in Pediatric Ulcerative Colitis","volume":"21","author":"Jalanka","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2026.01.224_bib0034","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00428-009-0825-8","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL\/Lcn2) is upregulated in gastric mucosa infected with Helicobacter pylori","volume":"455","author":"Alp\u00edzar-Alp\u00edzar","year":"2009","journal-title":"Virchows Arch"},{"key":"10.1016\/j.dld.2026.01.224_bib0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.chom.2009.03.011","article-title":"Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine","volume":"5","author":"Raffatellu","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.dld.2026.01.224_bib0036","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s10620-013-2676-z","article-title":"Relationship between neutrophil gelatinase-associated lipocalin (NGAL) levels and inflammatory bowel disease type and activity","volume":"58","author":"Ye\u015fil","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2026.01.224_bib0037","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-0-12-800263-6.00004-5","article-title":"Neutrophil gelatinase-associated lipocalin in cancer","volume":"64","author":"Lippi","year":"2014","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.dld.2026.01.224_bib0038","doi-asserted-by":"crossref","first-page":"37258","DOI":"10.1074\/jbc.M106089200","article-title":"The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B\/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL","volume":"276","author":"Yan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2026.01.224_bib0039","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.3390\/ijms20215280","article-title":"Long Non-Coding RNA GAS5 and Intestinal MMP2 and MMP9 Expression: A Translational Study in Pediatric Patients with IBD","volume":"20","author":"Lucaf\u00f2","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2026.01.224_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/643645","article-title":"Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases","volume":"2014","author":"Matusiewicz","year":"2014","journal-title":"Dis Markers"},{"key":"10.1016\/j.dld.2026.01.224_bib0041","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1124\/jpet.109.158022","article-title":"Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine","volume":"331","author":"Deng","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dld.2026.01.224_bib0042","doi-asserted-by":"crossref","first-page":"jjae197","DOI":"10.1093\/ecco-jcc\/jjae197","article-title":"Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease","volume":"19","author":"Preto","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2026.01.224_bib0043","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/ecco-jcc\/jjv148","article-title":"Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn\u2019s Disease","volume":"9","author":"de Bruyn","year":"2015","journal-title":"J Crohns Colitis"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826002574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826002574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:34:36Z","timestamp":1776238476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826002574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1590865826002574"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.01.224","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring novel biomarkers in pediatric ulcerative colitis: The role of Lipocalin-2, MMP-9, and MMP-9\/LCN-2 complex","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.01.224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}